---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-26-000006"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:44.542449+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical posts preliminary Q4 rev ~$269M (+12% YoY); 2026 guidance $1,003-1,013M

## Summary
- Preliminary Q4 2025 revenue ~$269M, up 12% YoY; full-year 2025 revenue ~$912M, up 14% YoY.
- Initial FY 2026 revenue guidance of $1,003M-$1,013M, implying 10-11% growth over 2025.
- Appointed Matt Osberg as EVP and CFO, start Jan 19, 2026; base salary $650k, sign-on $600k, equity awards $3M.
- Rick Buchholz steps down as CFO, serves as interim CFO through filing of 2025 10-K.

## SEC filing metadata
- accession: 0001609550-26-000006
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955026000006/0001609550-26-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955026000006/insp-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-26-000006
- JSON: https://secwatch.observer/filing/0001609550-26-000006.json
- Plain text: https://secwatch.observer/filing/0001609550-26-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.